Cell MedX Corp. logo

Cell MedX Corp. (CMXC)

Market Closed
24 Dec, 20:00
OTCQB OTCQB
$
0. 41
-0.04
-8.87%
$
126.33M Market Cap
- P/E Ratio
0% Div Yield
0 Volume
0 Eps
$ 0.45
Previous Close
Day Range
0.41 0.41
Year Range
0.01 0.5
Want to track CMXC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

CMXC Chart

Cell MedX Corp. Profile

Medical Devices Industry
Healthcare Sector
Mr. David M. Jeffs CEO
OTCQB Exchange
15115X107 Cusip
US Country
- Employees
- Last Dividend
5 Nov 2024 Last Split
- IPO Date
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. It also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is headquartered in Carson City, Nevada.

Contact Information

Address: 123 West Nye Lane, Carson City, NV, United States, 89706
Phone: 844 238 2692